- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Reprogramming.
Displaying page 1 of 1.
| EudraCT Number: 2019-002578-29 | Sponsor Protocol Number: 2019-5787 | Start Date*: 2020-01-21 |
| Sponsor Name:Radboudumc | ||
| Full Title: Functional Improvement of non-infarcT relaTed coronary artery stenosis by Extensive LDL-C Reduction with a PCSK9 Antibody. | ||
| Medical condition: Coronary artery disease (CAD) Optimal treatment approach for bystander lesions in non-infarct related arteries (non-IRA’s) has not been well established. Multiple RCT’s favor preventive PCI over ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-002311-39 | Sponsor Protocol Number: 101069207 | Start Date*: 2022-09-07 |
| Sponsor Name:University Of Cyprus | ||
| Full Title: Phase II trial for the use of ketotifen to enhance therapy in patients with sarcoma receiving standard chemotherapy | ||
| Medical condition: Patients with sarcoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CY (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-004376-11 | Sponsor Protocol Number: AZM-MD-302 | Start Date*: 2012-05-15 | |||||||||||
| Sponsor Name:Forest Research Institute, Inc. | |||||||||||||
| Full Title: A Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once-Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizat... | |||||||||||||
| Medical condition: Ventricular arrhythmia in patients with implantable cardioverter-defibrillator (ICD) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Prematurely Ended) NL (Prematurely Ended) ES (Prematurely Ended) DE (Prematurely Ended) SE (Prematurely Ended) CZ (Prematurely Ended) DK (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2013-000869-36 | Sponsor Protocol Number: CSPT-END-DIG-2012 | Start Date*: 2013-06-28 | |||||||||||
| Sponsor Name:Fundació Parc Taulí | |||||||||||||
| Full Title: Multidisciplinary approach versus conventional approach in colonic preparation of hospitalized patients. A randomized controlled trial | |||||||||||||
| Medical condition: Colon preparation for colonoscopy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-000197-30 | Sponsor Protocol Number: UoL001289 | Start Date*: 2018-07-13 |
| Sponsor Name:The University of Liverpool | ||
| Full Title: Sodium Valproate for Epigenetic Reprogramming in the Management of High Risk Oral Epithelial Dysplasia | ||
| Medical condition: High Risk Oral Epithelial Dysplasia | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-003752-79 | Sponsor Protocol Number: PIONEER | Start Date*: 2017-05-24 | |||||||||||
| Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | |||||||||||||
| Full Title: Randomised Phase II clinical trial PIONEER- A Pre-operative wIndOw study of letrozole plus PR agonist (Megestrol Acetate) versus letrozole aloNE in post-menopausal patients with ER-positive breast ... | |||||||||||||
| Medical condition: ER-positive, HER2-negative, invasive primary breast cancer of at least 1 cm size | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-002077-21 | Sponsor Protocol Number: ICR-CTSU/2017/10065 | Start Date*: 2019-04-18 | |||||||||||
| Sponsor Name:The Institute of Cancer Research | |||||||||||||
| Full Title: PHOENIX Trial: A pre-surgical window of opportunity and post-surgical adjuvant biomarker study of DNA damage response inhibition and/or anti-PD-L1 immunotherapy in patients with neoadjuvant chemoth... | |||||||||||||
| Medical condition: Triple Negative Breast Cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.